# Reboxetine for Sleep Apnoea After ENT Surgery

> **NCT05978505** · PHASE2 · RECRUITING · sponsor: **Flinders University** · enrollment: 20 (estimated)

## Conditions studied

- Sleep Apnea, Obstructive

## Interventions

- **DRUG:** Reboxetine 4 MG Oral Tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05978505
- **Lead sponsor:** Flinders University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-10
- **Primary completion:** 2025-07
- **Final completion:** 2025-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05978505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05978505, "Reboxetine for Sleep Apnoea After ENT Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05978505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*